The Valley Desk

NCT02798211 · Interventional trial

Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to Placebo

Overall registry status Completed

Phase 4

Conditions Psoriatic Arthritis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov